Страна: Австралия
Язык: английский
Источник: Department of Health (Therapeutic Goods Administration)
Peginterferon alfa-2b; Ribavirin
Merck Sharp & Dohme Australia Pty Ltd
Medicine Registered
Pegatron Combination Therapy PI A20130927 _ _ Page 1 of 41 PRODUCT INFORMATION PEGATRON ® COMBINATION THERAPY PEG-INTRON ® (PEGINTERFERON ALFA-2B) REDIPEN ® INJECTOR + REBETOL (RIBAVIRIN) CAPSULES NAME OF DRUG PEGATRON Combination Therapy is the brand name for composite packs containing peginterferon alfa-2b (rbe) for subcutaneous injection (PEG-INTRON) plus ribavirin capsules for oral administration (REBETOL). DESCRIPTION PEGINTERFERON ALFA-2B is a covalent conjugate of recombinant interferon alfa-2b with monomethoxy polyethylene glycol. The average molecular weight of the molecule is approximately 31,300 daltons. Peginterferon alfa-2b is predominantly composed of monopegylated species (one PEG molecule is attached to one interferon molecule), with only a small amount of dipegylated species. Fourteen different PEG attachment sites on the interferon molecule have been identified. CAS registry number: 215647-85-1. Recombinant interferon alfa-2b is obtained from a clone of _E. coli_, which harbours a genetically engineered plasmid hybrid encompassing an interferon alfa-2b gene from human leukocytes. RIBAVIRIN is a nucleoside analogue with antiviral activity. It is a white, crystalline powder which is freely soluble in water and slightly soluble in dehydrated alcohol. Ribavirin is 1- -D-ribofuranosyl- 1_H_-1,2,4-triazole-3-carboxamide with the following structural formula: CAS registry number: 36791-04-5 Mol. Wt: 244.21 PEGATRON COMBINATION THERAPY composite packs contain PEG-INTRON Redipen Injector and REBETOL Capsules. PEG-INTRON Redipen Injector is a single use disposable injection pen. The PEG-INTRON Powder for Injection and solvent are contained in sep Прочитать полный документ